June 28, 2017 8:26 PM ET

Life Sciences Tools and Services

Company Overview of Ogeda SA

Company Overview

Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs that target G-protein coupled receptors (GPCRs). It develops Fezolinetant, an oral, small-molecule antagonist of the NK3 receptor that reduces levels of the ovarian hormones estrogen and progesterone in a non-castrating manner as required for the treatment of uterine fibroids and endometriosis. The company also provides NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and ESN364, an orally-available lead product fezolinetant for the treatment of women’s health disorders in the areas of menopausal hot flashes. In addition, it offers pre-clinical drug discovery prog...

Route de Lennik 802

Brussels,  1070

Belgium

Founded in 1994

Phone:

32 2 529 00 11

Fax:

32 2 529 00 19

Key Executives for Ogeda SA

Chief Executive Officer, President & Director
Chief Financial Officer
Age: 52
Head of Services Unit - Euroscreen Fast
Director of Intellectual Property & Legal
Director of Business Development
Compensation as of Fiscal Year 2016.

Ogeda SA Key Developments

Euroscreen has Changed its Name to Ogeda

On October 19, 2016, Euroscreen changed its name to Ogeda.

Euroscreen S.A. Presents at BioEquity Europe 2016 Conference, May-10-2016

Euroscreen S.A. Presents at BioEquity Europe 2016 Conference, May-10-2016 . Venue: Scandic Hotel, Vester Soegade 6, 1601 Copenhagen, Denmark.

Euroscreen S.A. Presents at KBC Securities Healthcare Conference 2016, Mar-22-2016

Euroscreen S.A. Presents at KBC Securities Healthcare Conference 2016, Mar-22-2016 . Venue: Brussels, Brussels, Belgium. Speakers: Jean Combalbert, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Agristeps BVBA Europe
Archer Research BVBA Europe
Biosensource BVBA Europe
Diagenode s.a. Europe
DNAVision SA Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 2, 2017
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ogeda SA, please visit www.ogeda.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.